Page last updated: 2024-09-05

organophosphonates and Genital Herpes

organophosphonates has been researched along with Genital Herpes in 30 studies

Research

Studies (30)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (10.00)	18.2507
2000's	8 (26.67)	29.6817
2010's	19 (63.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrei, G; Gillemot, S; Snoeck, R; Topalis, D	1
Gormley, RH; Kovarik, CL; Rosenbach, M; Wanat, KA	1
Herold, BC; Jandl, T; Kiser, PF; Nagaraja, U; Nixon, B; Taneva, E; Teller, RS; Wang, Y	1
Cox, AP; Delany-Moretlwe, S; Foss, AM; Heise, L; Mertenskoetter, T; Meyer-Rath, G; Rees, H; Terris-Prestholt, F; Vickerman, P; Watts, CH	1
Baeten, JM; Celum, C; Donnell, D; Fife, KH; Hendrix, CW; Hong, T; Morrow, RA; Mujugira, A; Nakku-Joloba, E; Thomas, KK	1
Alt, C; Shankar, GN	1
Abdool Karim, Q; Abdool Karim, SS; Baxter, C; Gengiah, TN; Grobler, AC; Kashuba, A; Kharsany, AB; Mansoor, LE; Mindel, A; Samsunder, N; Werner, L	1
Abdool Karim, Q; Abdool Karim, SS; Gengiah, TN	1
Feder, HM	1
Agut, H; Boutolleau, D; Burrel, S	1
Baang, J	1
Bellacicco, AL; Buonavoglia, C; Camero, M; Crescenzo, G; Decaro, N; Martella, V; Neyts, J; Tarsitano, E; Tempesta, M	1
Cheshenko, N; Fakioglu, E; Herold, BC; Keller, MJ; Mesquita, PM; Wilson, SS	1
Andrei, G; Balestra, E; Balzarini, J; Cihlar, T; Introini, A; Lisco, A; Margolis, L; Perno, CF; Snoeck, R; van den Oord, J; Vanpouille, C	1
Baum, MM; Butkyavichene, I; Clark, MR; Friend, DR; Gilman, J; Kennedy, S; Kopin, E; Malone, AM; Moss, JA; Motamedi, M; Nguyen, C; Smith, TJ; Vincent, KL	1
Friend, DR	1
Herold, BC; Huber, AM; Kiser, PF; Mesquita, PM; Rastogi, R; Segarra, TJ; Teller, RS; Torres, NM	1
Abdool Karim, Q; Abdool Karim, SS; Altfeld, M; Carr, WH; Naranbhai, V; Ndung'u, T	1
Abdool Karim, Q; Abdool Karim, SS; Altfeld, M; Carr, WH; Durgiah, R; Naranbhai, V; Samsunder, N; Sibeko, S	1
Melchjorsen, J; Paludan, SR; Reinert, LS; Søgaard, OS; Tolstrup, M; Vibholm, L; Østergaard, L	1
Cohen, J	1
Alessi, E; Cusini, M; Ghislanzoni, M; Zerboni, R	1
Bellacicco, AL; Buonavoglia, C; Camero, M; Crescenzo, G; Decaro, N; Elia, G; Martella, V; Neyts, J; Tarsitano, E; Tempesta, M; Thiry, E; Thiry, J	1
Andrei, G; Balzarini, J; Clumeck, N; De Clercq, E; Gérard, M; Hedderman, A; Sadzot-Delvaux, C; Silverman, A; Snoeck, R; Tricot, G	1
Bravo, FJ; Kern, ER; Kier, AB; Stanberry, LR; Vogt, PE	1
Diaz-Mitoma, F; Hughes, A; Jaffe, HS; McGuire, B; Rudy, J; Sacks, SL; Safrin, S; Shafran, SD; Sibbald, RG; Trottier, S	1
Norwood, CW; Oster, CN; Sparling, JD; Turiansky, GW	1
Ait Arkoub, Z; Arnulf, B; Chebbi, F; Fillet, AM; Lefrere, F; Varet, B	1
Bestman-Smith, J; Boivin, G	1

Reviews

1 review(s) available for organophosphonates and Genital Herpes

Article	Year
Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission. Expert opinion on drug delivery, 2012, Volume: 9, Issue:4 Topics: Adenine; Administration, Intravaginal; Anti-Infective Agents; Antiviral Agents; Biopharmaceutics; Contraception; Disease Transmission, Infectious; Drug Delivery Systems; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy, Unplanned; Tenofovir	2012

Article

Year

Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.

Expert opinion on drug delivery, 2012, Volume: 9, Issue:4

Topics: Adenine; Administration, Intravaginal; Anti-Infective Agents; Antiviral Agents; Biopharmaceutics; Contraception; Disease Transmission, Infectious; Drug Delivery Systems; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy, Unplanned; Tenofovir

2012

Trials

3 trial(s) available for organophosphonates and Genital Herpes

Article	Year
Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial. Annals of internal medicine, 2014, 07-01, Volume: 161, Issue:1 Topics: Adenine; Administration, Oral; Adult; Anti-Retroviral Agents; Antiviral Agents; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; Herpes Genitalis; Herpesvirus 2, Human; Heterosexuality; HIV Infections; HIV Seronegativity; HIV-1; Humans; Incidence; Male; Medication Adherence; Organophosphonates; RNA, Viral; Tenofovir	2014
Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection. The New England journal of medicine, 2015, Aug-06, Volume: 373, Issue:6 Topics: Adenine; Administration, Intravaginal; Adult; Double-Blind Method; Female; Follow-Up Studies; Gels; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Seronegativity; Humans; Incidence; Kaplan-Meier Estimate; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Young Adult	2015
A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:11 Topics: Adult; Aged; Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gels; Herpes Genitalis; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Recurrence	1998

Other Studies

26 other study(ies) available for organophosphonates and Genital Herpes

Article	Year
The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase. The Journal of infectious diseases, 2018, 02-14, Volume: 217, Issue:5 Topics: Acyclovir; Amino Acid Substitution; Antiviral Agents; Cells, Cultured; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Mutation, Missense; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Selection, Genetic; Sequence Analysis, DNA; Tenofovir; Viral Proteins	2018
Intralesional cidofovir for treating extensive genital verrucous herpes simplex virus infection. JAMA dermatology, 2013, Volume: 149, Issue:7 Topics: Antiviral Agents; Cidofovir; Coinfection; Cytosine; Hepatitis C; Herpes Genitalis; HIV Infections; Humans; Injections, Intralesional; Male; Middle Aged; Organophosphonates	2013
Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Adenine; Administration, Intravaginal; Animals; Antiviral Agents; Contraceptive Devices, Female; Disease Models, Animal; Drug Administration Schedule; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Mice; Mice, Inbred BALB C; Organophosphonates; Survival Analysis; Tenofovir; Vagina; Vaginal Creams, Foams, and Jellies	2014
Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices. BMC infectious diseases, 2014, Jan-09, Volume: 14 Topics: Adenine; Anti-HIV Agents; Circumcision, Male; Cost-Benefit Analysis; Female; Forecasting; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Seropositivity; Humans; Incidence; Male; Models, Economic; Organophosphonates; Prevalence; South Africa; Tenofovir	2014
Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:12 Topics: Acrylic Resins; Acyclovir; Adenine; Animals; Anti-Infective Agents; Chlorocebus aethiops; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Female; Herpes Genitalis; Herpesvirus 2, Human; Mice, Inbred BALB C; Organophosphonates; Poloxamer; Rabbits; Rats, Sprague-Dawley; Tenofovir; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vero Cells	2014
Tenofovir Gel to Prevent HSV-2 Infection. The New England journal of medicine, 2015, 11-12, Volume: 373, Issue:20 Topics: Adenine; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Organophosphonates; Reverse Transcriptase Inhibitors	2015
Tenofovir Gel to Prevent HSV-2 Infection. The New England journal of medicine, 2015, 11-12, Volume: 373, Issue:20 Topics: Adenine; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Organophosphonates; Reverse Transcriptase Inhibitors	2015
Tenofovir Gel to Prevent HSV-2 Infection. The New England journal of medicine, 2015, 11-12, Volume: 373, Issue:20 Topics: Adenine; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Organophosphonates; Reverse Transcriptase Inhibitors	2015
Pericoital application of tenofovir gel reduced risk for herpes simplex virus type 2 in HIV-negative women. Annals of internal medicine, 2015, Dec-15, Volume: 163, Issue:12 Topics: Adenine; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Organophosphonates; Reverse Transcriptase Inhibitors	2015
Assessing the efficacy of cidofovir against herpesvirus-induced genital lesions in goats using different therapeutic regimens. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Animals; Antiviral Agents; Base Sequence; Cidofovir; Cytosine; Disease Models, Animal; DNA Primers; DNA, Viral; Female; Genital Diseases, Female; Goat Diseases; Goats; Herpes Genitalis; Herpesviridae Infections; Humans; Organophosphonates; Species Specificity; Vaginal Creams, Foams, and Jellies; Varicellovirus	2008
Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety. Antiviral therapy, 2009, Volume: 14, Issue:8 Topics: Adenine; Administration, Intravaginal; Animals; Anti-Infective Agents; Antiviral Agents; Biomarkers; Disease Models, Animal; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; Mice; Mice, Inbred BALB C; Naphthalenesulfonates; Nonoxynol; Organophosphonates; Polymers; Predictive Value of Tests; Risk Assessment; Tenofovir	2009
Prevention. Study reveals that vaginal gel reduces HIV, herpes. AIDS policy & law, 2010, Volume: 25, Issue:10 Topics: Adenine; Female; Gels; Herpes Genitalis; HIV Infections; Humans; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Vagina	2010
Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication. Cell host & microbe, 2011, Oct-20, Volume: 10, Issue:4 Topics: Adenine; Administration, Topical; Animals; Anti-Infective Agents; Cells, Cultured; DNA-Directed DNA Polymerase; DNA, Viral; Exodeoxyribonucleases; Herpes Genitalis; Herpesvirus 2, Human; HIV Reverse Transcriptase; Humans; Mice; Molecular Sequence Data; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Sequence Analysis, DNA; Tenofovir; Thymidine Kinase; Viral Proteins	2011
Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2 Topics: Acyclovir; Adenine; Administration, Intravaginal; Animals; Anti-HIV Agents; Antiviral Agents; Delayed-Action Preparations; Disease Models, Animal; Drug Combinations; Drug Delivery Systems; Equipment Design; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Organophosphonates; Rabbits; Sexually Transmitted Diseases, Viral; Tenofovir; Treatment Outcome	2012
Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:7 Topics: Adenine; Antiviral Agents; Cell Culture Techniques; Chemoprevention; Contraceptive Devices, Female; Female; Herpes Genitalis; HIV; HIV Infections; Humans; Organ Culture Techniques; Organophosphonates; Simplexvirus; Tenofovir	2012
Natural killer cell function in women at high risk for HIV acquisition: insights from a microbicide trial. AIDS (London, England), 2012, Sep-10, Volume: 26, Issue:14 Topics: Adenine; Administration, Topical; Adult; Anti-HIV Agents; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Proliferation; Clinical Trials as Topic; Disease Susceptibility; Female; Flow Cytometry; Herpes Genitalis; HIV Seropositivity; HIV-1; Humans; Interferon-gamma; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Middle Aged; Organophosphonates; Risk Assessment; Sexual Behavior; South Africa; Tenofovir; Vaginal Creams, Foams, and Jellies	2012
Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel. The Journal of infectious diseases, 2012, Oct-01, Volume: 206, Issue:7 Topics: Adenine; Adult; Anti-HIV Agents; Avian Proteins; Case-Control Studies; Coinfection; Cytokines; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; Humans; Immunity, Innate; Logistic Models; Lymphocyte Activation; Organophosphonates; Platelet Count; Principal Component Analysis; Randomized Controlled Trials as Topic; Risk Factors; Tenofovir; Vaginal Creams, Foams, and Jellies; Young Adult	2012
Antiviral and immunological effects of tenofovir microbicide in vaginal herpes simplex virus 2 infection. AIDS research and human retroviruses, 2012, Volume: 28, Issue:11 Topics: Adenine; Administration, Topical; Animals; Anti-Infective Agents; Antiviral Agents; Cells, Cultured; Disease Models, Animal; Female; Herpes Genitalis; Interferon-gamma; Interleukin-2; Mice; Mice, Inbred C57BL; Organophosphonates; Tenofovir; Tumor Necrosis Factor-alpha; Vagina; Vaginal Creams, Foams, and Jellies; Virus Shedding	2012
HIV/AIDS. Prevention cocktails: combining tools to Stop HIV's spread. Science (New York, N.Y.), 2005, Aug-12, Volume: 309, Issue:5737 Topics: Acyclovir; Adenine; Anti-HIV Agents; Antidepressive Agents, Second-Generation; Antiviral Agents; Bupropion; Circumcision, Male; Clinical Trials as Topic; Contraceptive Devices, Female; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV; HIV Infections; Humans; Hygiene; Male; Organophosphonates; Sexual Behavior; Tenofovir; Viral Load	2005
Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man. Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:7 Topics: Acyclovir; Administration, Topical; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chronic Disease; Cidofovir; Cytosine; Drug Resistance, Viral; Drug Therapy, Combination; Foscarnet; Herpes Genitalis; HIV Infections; Humans; Male; Middle Aged; Organophosphonates	2006
Potent inhibition of genital herpesvirus infection in goats by cidofovir. Antiviral therapy, 2007, Volume: 12, Issue:6 Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Goats; Herpes Genitalis; Herpesviridae Infections; Organophosphonates; Varicellovirus	2007
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:4 Topics: Acyclovir; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; DNA Restriction Enzymes; DNA, Viral; Drug Resistance, Microbial; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Opportunistic Infections; Organophosphonates; Organophosphorus Compounds; Skin Diseases, Viral; Thymidine Kinase	1994
Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs. Antiviral research, 1993, Volume: 21, Issue:1 Topics: Acyclovir; Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Female; Guinea Pigs; Herpes Genitalis; Mice; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Ultraviolet Rays; Vagina; Vaginal Diseases; Virus Replication	1993
Diagnostic and therapeutic dilemmas of a large scrotal lesion in an AIDS patient. The AIDS reader, 2001, Volume: 11, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Biopsy; Cidofovir; Cytosine; Diagnosis, Differential; Fluorescent Antibody Technique, Direct; Herpes Genitalis; Herpesvirus 2, Human; Humans; Hyperplasia; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Scrotum; Skin; Skin Ulcer	2001
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient. Bone marrow transplantation, 2001, Volume: 28, Issue:8 Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Combined Modality Therapy; Cyclosporine; Cytarabine; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Herpes Genitalis; Herpes Simplex; Humans; Hydroxyurea; Immunocompromised Host; Immunosuppressive Agents; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Transplantation Conditioning; Whole-Body Irradiation	2001
Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapy. Journal of medical virology, 2002, Volume: 67, Issue:1 Topics: Adenine; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; Humans; Organophosphonates; Reverse Transcriptase Inhibitors	2002